The outsourcing of research and development (R&D) activities has grown rapidly in recent years. Outsourcing has major implications for how knowledge and R&D activities are organised and coordinated in a wider open innovation environment and creates major challenges for firms and their managers. This paper explores the implications of outsourcing and the increasingly distributed nature of research and innovative activities using primary survey data collected from the UK pharmaceutical industry. These issues are uniquely examined at both firm and activity level. This paper then seeks to set the findings of the study within the context of the wider debate and conceptual frameworks surrounding R&D outsourcing and offshoring in terms of the incr...
Whilst the interest in open innovation is growing, thus far few studies have emphasised its importan...
Logistics outsourcing is a practice commonly used by firms to allow them to access capabilities that...
The global pharmaceutical industry is facing diminishing returns from its massive investment in rese...
Outsourcing of research and development (R&D) activities has become a major management issue for R&D...
This paper examines the outsourcing patterns of U.S. firms in the biopharmaceutical industry. Data f...
The stimulation of innovation in the pharmaceutical industry through outsourcing of research and dev...
Companies are increasingly under pressure to be more efficient both in terms of costs and overall pe...
In this paper, we develop a framework of outsoucing research by providing a distictive view on the (...
Pharmaceutical sector as a global-born and knowledge-based economy, is well noted with its extensive...
Based on a sample of UK manufacturing small- and medium-sized firms in the engineering and electroni...
The drug discovery and development subsector lies at the heart of the pharmaceutical and biotechnolo...
The institutionalization of R&D by large, modern organizations is regarded as one of the most signif...
A history of government drug regulation and the relationship between the pharmaceutical companies in...
This study of the organisation of the discovery function by large US pharmaceutical companies (LPCs)...
Abstract copyright UK Data Service and data collection copyright owner.Western multinationals are no...
Whilst the interest in open innovation is growing, thus far few studies have emphasised its importan...
Logistics outsourcing is a practice commonly used by firms to allow them to access capabilities that...
The global pharmaceutical industry is facing diminishing returns from its massive investment in rese...
Outsourcing of research and development (R&D) activities has become a major management issue for R&D...
This paper examines the outsourcing patterns of U.S. firms in the biopharmaceutical industry. Data f...
The stimulation of innovation in the pharmaceutical industry through outsourcing of research and dev...
Companies are increasingly under pressure to be more efficient both in terms of costs and overall pe...
In this paper, we develop a framework of outsoucing research by providing a distictive view on the (...
Pharmaceutical sector as a global-born and knowledge-based economy, is well noted with its extensive...
Based on a sample of UK manufacturing small- and medium-sized firms in the engineering and electroni...
The drug discovery and development subsector lies at the heart of the pharmaceutical and biotechnolo...
The institutionalization of R&D by large, modern organizations is regarded as one of the most signif...
A history of government drug regulation and the relationship between the pharmaceutical companies in...
This study of the organisation of the discovery function by large US pharmaceutical companies (LPCs)...
Abstract copyright UK Data Service and data collection copyright owner.Western multinationals are no...
Whilst the interest in open innovation is growing, thus far few studies have emphasised its importan...
Logistics outsourcing is a practice commonly used by firms to allow them to access capabilities that...
The global pharmaceutical industry is facing diminishing returns from its massive investment in rese...